Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × Specimen Handling × Clear all

Sponsor

Conditions

Neoplasm Metastasis 7 Multiple Myeloma 7 Lung Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Neuroblastoma 5 Melanoma 5 Fallopian Tube Neoplasms 5 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Malignant Solid Neoplasm 3 Leukemia, Biphenotypic, Acute 3 Histiocytosis, Langerhans-Cell 3 Hepatoblastoma 3 Hematologic Neoplasms 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Small Cell Lung Carcinoma 2

Interventions

Gemcitabine 11 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 Leucovorin 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡